Fabry Disease Pipeline Market – Gene Therapy and Next‑Gen ERT...

ha aggiunto una foto Wellness

2026-08-12 07:08:12 -

Fabry Disease Pipeline Market – Gene Therapy and Next‑Gen ERT Reshape a Rare Disease Landscape

The Fabry disease pipeline market is focused on emerging therapies for this rare, X‑linked lysosomal storage disorder caused by alpha‑galactosidase A deficiency. With a growing emphasis on disease‑modifying and potentially curative approaches, the pipeline is shifting from traditional enzyme replacement toward gene therapy, chaperones, and substrate reduction strategies. The market was valued...

0 Commenti 0 condivisioni 16 Views 0 Anteprima